|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qin G, Dang M, Gao H, Wang H, Luo F and
Chen R: Deciphering the protein-protein interaction network
regulating hepatocellular carcinoma metastasis. Biochim Biophys
Acta Proteins Proteom. 1865:1114–1122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carr BI: Hepatocellular carcinoma: Current
management and future trends. Gastroenterology. 127 (Suppl
1):S218–S224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lopez PM, Villanueva A and Llovet JM:
Systematic review: Evidence-based management of hepatocellular
carcinoma-an updated analysis of randomized controlled trials.
Aliment Pharmacol Ther. 23:1535–1547. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chu C, Spitale RC and Chang HY:
Technologies to probe functions and mechanisms of long noncoding
RNAs. Nat Struct Mol Biol. 22:29–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Wang R, Zhang K and Chen LB: Long
non-coding RNAs in non-small cell lung cancer as biomarkers and
therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y, Chen L, Gu J, Zhang H, Yuan J,
Lian Q, Lv G, Wang S, Wu Y, Yang YT, et al: Recurrently deregulated
lncRNAs in hepatocellular carcinoma. Nat Commun. 8:144212017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu S, Liu J, Wang X, Li M, Chen Z and Tang
Y: Aberrant expression of the long non-coding RNA GHRLOS and its
prognostic significance in patients with colorectal cancer. J
Cancer. 8:4040–4047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang H, Shi X, Ye G, Xu Y, Xu J, Lu J and
Lu W: Up-regulated long non-coding RNA DUXAP8 promotes cell growth
through repressing Krüppel-like factor 2 expression in human
hepatocellular carcinoma. Onco Targets Ther. 12:7429–7436. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng Y, Nie P and Xu S: Long noncoding
RNA linc00467 plays an oncogenic role in hepatocellular carcinoma
by regulating the miR-18a-5p/NEDD9 axis. J Cell Biochem.
121:3135–3144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng
B, Nong S and Qin H: Long non-coding RNA F11-AS1 inhibits
HBV-related hepatocellular carcinoma progression by regulating
NR1I3 via binding to microRNA-211-5p. J Cell Mol Med. 24:1848–1865.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Yang F, Zhang L, Chen J, Zhao Z,
Wang H, Wu F, Liang T, Yan X, Li J, et al: LncRNA profile study
reveals four-lncRNA signature associated with the prognosis of
patients with anaplastic gliomas. Oncotarget. 7:77225–77236. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zan XY and Li L: Construction of
lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA
biomarkers in glioblastomas. Oncol Lett. 17:4369–4374.
2019.PubMed/NCBI
|
|
17
|
Jiang H, Huang G, Zhao N, Zhang T, Jiang
M, He Y, Zhou X and Jiang X: Long non-coding RNA TPT1-AS1 promotes
cell growth and metastasis in cervical cancer via acting AS a
sponge for miR-324-5p. J Exp Clin Cancer Res. 37:1692018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia L, Song Y, Mu L, Li Q, Tang J, Yang Z
and Meng W: Long noncoding RNA TPT1-AS1 downregulates the
microRNA-770-5p expression to inhibit glioma cell autophagy and
promote proliferation through STMN1 upregulation. J Cell Physiol.
235:3679–3689. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang J, Huang F, Wang H, Cheng F, Pi Y,
Zhao J and Li Z: Knockdown of TPT1-AS1 inhibits cell proliferation,
cell cycle G1/S transition, and epithelial-mesenchymal transition
in gastric cancer. Bosn J Basic Med Sci. 21:39–46. 2021.PubMed/NCBI
|
|
20
|
Mirsadraee S, Oswal D, Alizadeh Y, Caulo A
and van Beek E Jr: The 7th lung cancer TNM classification and
staging system: Review of the changes and implications. World J
Radiol. 4:128–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang ZL, Li W, Chen QF, Wu PH and Shen
LJ: Eight key long non-coding RNAs predict hepatitis virus positive
hepatocellular carcinoma as prognostic targets. World J
Gastrointest Oncol. 11:983–997. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu W, Gao H, Li X, Zhu Y, Peng S, Yu J,
Zhan G, Wang J, Liu N and Guo X: LncRNA TPT1-AS1 promotes
tumorigenesis and metastasis in epithelial ovarian cancer by
inducing TPT1 expression. Cancer Sci. 110:1587–1598. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He Y, Vogelstein B, Velculescu VE,
Papadopoulos N and Kinzler KW: The antisense transcriptomes of
human cells. Science. 322:1855–1857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Munroe SH and Zhu J: Overlapping
transcripts, double-stranded RNA and antisense regulation: A
genomic perspective. Cell Mol Life Sci. 63:2102–1218. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Faghihi MA and Wahlestedt C: Regulatory
roles of natural antisense transcripts. Nat Rev Mol Cell Biol.
10:637–643. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18:282019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin L, Chen Y, Zhou Y, Deng G, Han Y, Guo
C, Li Y, Zeng S and Shen H: Increased long noncoding RNA LASP1-AS
is critical for hepatocellular carcinoma tumorigenesis via
upregulating LASP1. J Cell Physiol. 234:13493–13509. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji D, Hu G, Zhang X, Yu T and Yang J: Long
non-coding RNA DSCAM-AS1 accelerates the progression of
hepatocellular carcinoma via sponging miR-338-3p. Am J Transl Res.
11:4290–4302. 2019.PubMed/NCBI
|
|
30
|
Ye D, Luo H, Lai Z, Zou L, Zhu L, Mao J,
Jacob T, Ye W, Wang L and Chen L: ClC-3 chloride channel proteins
regulate the cell cycle by up-regulating cyclin D1-CDK4/6 through
suppressing p21/p27 expression in nasopharyngeal carcinoma cells.
Sci Rep. 6:302762016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z,
Zhao Y, Xu C and Zhang S: Cyclin-dependent kinase inhibitor 3
promoted cell proliferation by driving cell cycle from G1 to S
phase in esophageal squamous cell carcinoma. J Cancer.
10:1915–1922. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang F, Qi X, Li Z, Jin S, Xie Y and Zhong
H: lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion
via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag
Res. 11:3813–3828. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma C, Huang S, Xu L, Tian L, Yang Y and
Wang J: Transcription co-activator P300 activates Elk1-aPKC-ι
signaling mediated epithelial-to-mesenchymal transition and
malignancy in hepatocellular carcinoma. Oncogenesis. 9:322020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Xu J, Zhang S, An J, Zhang J,
Huang J and Jin Y: HOXA-AS2 promotes proliferation and induces
epithelial-mesenchymal transition via the miR-520c-3p/GPC3 axis in
hepatocellular carcinoma. Cell Physiol Biochem. 50:2124–2138. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Liu G, Li X, Dong H, Xiao W and Lu
S: Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma
progression through regulation of miR-140-5p-TGFBR1 pathway.
Biochem Biophys Res Commun. 503:2826–2832. 2018. View Article : Google Scholar : PubMed/NCBI
|
